Business

Pfizer, BioNTech, Weber and others

Check out the companies that make headlines before the alarm goes off:

Pfizer (PFE), BioNTech (BNTX) – The companies say studies show that three doses of their Covid-19 vaccine neutralized the omicron variant, while two doses remained protective. Pfizer and BioNTech also said they are continuing to work on an omicron-specific vaccine. Pfizer and BioNTech hit previous lows in the market as of the news, with Pfizer up 1.4% and BioNTech reducing losses to 1.5%.

Campbell Soup (CPV) – The food maker beat estimates by 8 cents with adjusted quarterly earnings of 89 cents per share, though revenue was slightly lower than analysts’ forecasts. Campbell says demand for its products remains strong, and it can cushion the impact of higher input costs through dramatic improvements in price and productivity. Shares were up 1.4% in money markets.

Thor Industries (THO) – The entertainment media maker earned $4.34 per share in its latest quarter, well above the consensus estimate of $3.24. Revenue also beat Wall Street forecasts amid continued strong demand. Thor is up 6% in pre-market trading.

Weber (WEBR) – Shares of the baked goods maker rose 1% in money markets after reporting a narrower-than-expected loss in its most recent quarter and beating Wall Street’s revenue forecasts. Weber lost 13 cents per share, 5 cents less than analysts had predicted.

Repairs (SFIX) – Stitch suffered a 23.9% drop in money markets after issuing guidance for current-quarter revenue and member indexes that differed from Wall Street forecasts. The online clothing retailer posted a narrower-than-expected loss for its most recent quarter and better-than-expected revenue, but not enough to shake investors’ concerns.

ChargePoint Holdings (CHPT) – ChargePoint adjusted a loss of 14 cents per share in its latest quarter, 1% higher than anticipated, while the toll network operator had slightly higher revenue than estimates. . The company issued stronger-than-expected current-quarter revenue guidance and raised its full-year outlook. Despite the upbeat outlook, ChargePoint fell 2.7% in pre-market trading.

PagerDuty (PD) – PagerDuty reported an adjusted quarterly loss of 7 cents per share, 2 cents narrower than analysts had anticipated, while revenue topped Street forecasts. The IT-responsive software maker also gave better-than-expected current-quarter revenue guidance, and its stock jumped 10.9% in pre-sale performance.

Fees are collected by brothers (TOL) – Toll Brothers earned $3.02 per share in its latest quarter, versus a consensus estimate of $2.49, while the luxury home builder also reported revenue. better than expected. It also projects 20% growth in its fiscal 2022 revenue as demand remains buoyant. Fees added 1.5% in the precursor market.

Robin Hood hero (HOOD) – Robinhood has filed to end a plan to sell shares by supporters of the trading platform company. Shares were up 3% in money markets.

Black stones (BLK) – The asset management company is taking about $2 trillion in assets from The road for government (STT), used to be the sole custodian of BlackRock’s ETFs. BlackRock will transfer some custody of its ETF to Citigroup (C), JPMorgan Chase (JPM) and Bank of America (BAC).

Dave & Buster’s (PLAY) – Dave & Buster estimates an 8-cent increase in quarterly profit of 23 cents per share, while the entertainment center-themed restaurant operator also posted revenue that beat forecasts for the street. city. Dave & Buster’s is up 4.5% in the money market.

https://www.cnbc.com/2021/12/08/stocks-making-the-biggest-moves-premarket-pfizer-biontech-weber-and-others-.html Pfizer, BioNTech, Weber and others

Emma James

Internetcloning is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – admin@internetcloning.com. The content will be deleted within 24 hours.

Related Articles

Back to top button